Download PDF
Arthritis und Rheuma 2017; 37(02): 142-146
DOI: 10.1055/s-0037-1618411
Kinderrheumatologie/Kasuistik
Schattauer GmbH

Rezidivierende Monarthritiden kleiner Gelenke: atypisches Leitsymptom eines spät erkannten familiären Mittelmeerfiebers

S. Mrusek
1   Rheumatologische Praxisgemeinschaft, Baden-Baden
,
G. Ganser
2   Klinik für Kinder- und Jugendrheumatologie, Rheumatologisches Kompetenzzentrum Nordwestdeutschland, St. Josef-Stift Sendenhorst, Sendenhorst
› Author Affiliations
Further Information

Publication History

Publication Date:
27 December 2017 (online)

  PDF Download  Permissions and Reprints
 

  • Literatur

  • 1 Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Gen 2001; 9: 473-483.
    CrossrefPubMedGoogle Scholar
  • 2 Caglayan AO, Demiryilmaz F, Ozyazgan I, Gumus H. MEFV gene compound heterozygous mutations in familial Mediterranean fever phenotype: a retrospective clinical and molecular study. Nephrol Dial Transplant 2010; 25: 2520-2523.
    CrossrefPubMedGoogle Scholar
  • 3 Giancane G, Ter Haar NM, Wulffraat N. et al. Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever. Ann Rheum Dis 2015; 74 (04) 635-641.
    CrossrefPubMedGoogle Scholar
  • 4 Livneh A, Langevitz P, Zemer D. et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40: 1879-1885.
    CrossrefPubMedGoogle Scholar
  • 5 Erten S, Erzurum C, Altunoglu A. Three family members with familial Mediterranean fever carrying the M694V mutation showed different clinical presentations. Intern Med 2012; 51: 1765-1768.
    CrossrefPubMedGoogle Scholar
  • 6 Shohat M, Halpern GJ. Familial Mediterranean fever - A review. Genet Med 2011; 13 (06) 487-498.
    CrossrefPubMedGoogle Scholar
  • 7 Soriano A, Manna R. Familial Mediterranean fever: new phenotypes. Autoimmun Rev 2012; 12 (01) 31-37.
    CrossrefPubMedGoogle Scholar
  • 8 Brik R, Shinwani M, Kasinetz L, Gershoni-Baruch R. The musculoskeletal manifestations of familial Mediterranen fever in children genetically diagnosed with the disease. Arthritis Rheum 2001; 44: 1416-1419.
    CrossrefPubMedGoogle Scholar
  • 9 Lidar M, Kedem R, Mor A, et al. Levartovsky D, Langevitz P, Livneh A. Arthritis as the sole episodic manifestation of familial Mediterranean fever. J Rheumatol 2005; 32: 859-862.
    Google Scholar
  • 10 Uthman I, El-Sayyad J, El-hajj I, Bizri A. Familial Mediterranean fever mimicking septic arthritis. Rheumatol Int 2005; 25: 633-634.
    CrossrefPubMedGoogle Scholar
  • 11 Kallinich T, Haffner D, Niehues T. et al. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics 2007; 119 (02) e474-e483.
    CrossrefPubMedGoogle Scholar
  • 12 Padeh S, Gerstein M, Berkun Y. Colchicine is a safe drug in children with familial Mediterranean fever. J Pediatr 2012; 161: 1142-1146.
    CrossrefPubMedGoogle Scholar
  • 13 Sayarlioglu M, Sayarlioglu H, Ozen S. et al. Colchicine-induced myopathy in a teenager with familial Mediterranean fever. Ann Pharmacother 2003; 37: 1821-1824.
    CrossrefPubMedGoogle Scholar
  • 14 Harel L, Mukamel M, Amir J. et al. Colchicine-induced myoneuropathy in childhood. Eur J Pediatr 1998; 157: 853-855.
    CrossrefPubMedGoogle Scholar
  • 15 Eroglu FK, Beşbaş N, Topaloglu R, Ozen S. Treatment of colchicine-resistant familial Mediterranean fever in children and adolescents. Rheumatol Int 2015; 35 (10) 1733-1737.
    CrossrefPubMedGoogle Scholar
  • 16 Başaran Ö , Uncu N, Celikel BA. et al. Interleukin-1 targeting treatment in familial Mediterranean fever: an experience of pediatric patients. Mod Rheumatol 2015; 25 (04) 621-624.
    CrossrefPubMedGoogle Scholar
  • 17 Mukhin NA, Kozlovskaya LV, Bogdanova MV. et al. Predictors of AA amyloidosis in familial Mediterranean fever. Rheumatol Int 2015; 35: 1257-1262.
    CrossrefPubMedGoogle Scholar